Avacta Group Plc (OTCMKTS:AVCTF – Get Free Report) shares were down 3% during mid-day trading on Monday . The company traded as low as $0.82 and last traded at $0.82. Approximately 200 shares were traded during trading, a decline of 92% from the average daily volume of 2,644 shares. The stock had previously closed at $0.84.
Avacta Group Price Performance
The business’s 50-day moving average price is $0.85 and its 200 day moving average price is $0.73.
Avacta Group Company Profile
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Featured Articles
- Five stocks we like better than Avacta Group
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- Compound Interest and Why It Matters When Investing
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- 5 discounted opportunities for dividend growth investors
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
